Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

NCT00279045 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4426

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Rosiglitazone
DRUG: glyburide
DRUG: metformin

Sponsor

GlaxoSmithKline